[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tango Therapeutics Inc (TNGX)

Tango Therapeutics Inc (TNGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tango Therapeutics Inc 201 BROOKLINE AVE. SUITE 901 BOSTON MA 02215 USA

www.tangotx.com Employees: 137 P: 857-320-4900

Sector:

Medical

Description:

Tango Therapeutics Inc. is a biotechnology company. It focused on discovering and delivering precision cancer medicines. Tango Therapeutics Inc., formerly known as BCTG Acquisition Corp., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 3,179,363
Enterprise Value, $K 3,066,653
Shares Outstanding, K 144,648
Float, K 135,246
% Float 93.50%
Short Interest, K 38,251
Short Float 26.44%
Days to Cover 12.51
Short Volume Ratio 0.53
% of Insider Shareholders 6.50%
% of Institutional Shareholders 78.99%

Financials:

Annual Sales, $ 62,380 K
Annual Net Income, $ -101,590 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -38,750 K
EBIT, $ -111,290 K
EBITDA, $ -111,700 K

Growth:

1-Year Return 1,032.99%
3-Year Return 589.03%
5-Year Return 100.73%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.32 on 05/13/26
Next Earnings Date 08/04/26
Earnings Per Share ttm -0.87
EPS Growth vs. Prev Qtr -10.34%
EPS Growth vs. Prev Year 11.11%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

TNGX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.54%
Return-on-Assets % -33.44%
Profit Margin % -162.86%
Debt/Equity 0.00
Price/Sales 46.37
Price/Cash Flow N/A
Price/Book 7.37
Book Value/Share 2.57
Interest Coverage -1.45
60-Month Beta 1.22
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.